title: Adiponectin regulates albuminuria and podocyte function in mice.
abstract: Increased albuminuria is associated with obesity and diabetes and is a risk factor for cardiovascular and renal disease. However, the link between early albuminuria and adiposity remains unclear. To determine whether adiponectin, an adipocyte-derived hormone, is a communication signal between adipocytes and the kidney, we performed studies in a cohort of patients at high risk for diabetes and kidney disease as well as in adiponectin-knockout (Ad(-/-)) mice. Albuminuria had a negative correlation with plasma adiponectin in obese patients, and Ad(-/-) mice exhibited increased albuminuria and fusion of podocyte foot processes. In cultured podocytes, adiponectin administration was associated with increased activity of AMPK, and both adiponectin and AMPK activation reduced podocyte permeability to albumin and podocyte dysfunction, as evidenced by zona occludens-1 translocation to the membrane. These effects seemed to be caused by reduction of oxidative stress, as adiponectin and AMPK activation both reduced protein levels of the NADPH oxidase Nox4 in podocytes. Ad(-/-) mice treated with adiponectin exhibited normalization of albuminuria, improvement of podocyte foot process effacement, increased glomerular AMPK activation, and reduced urinary and glomerular markers of oxidant stress. These results suggest that adiponectin is a key regulator of albuminuria, likely acting through the AMPK pathway to modulate oxidant stress in podocytes.
authors.affiliation: Translational Research in Kidney Disease, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0711, La Jolla, California 92093-0711, USA. KumarSharma@ucsd.edu
authors.forename: Kumar
authors.initials: K
authors.lastname: Sharma
authors.forename: Satish
authors.initials: S
authors.lastname: Ramachandrarao
authors.forename: Gang
authors.initials: G
authors.lastname: Qiu
authors.forename: Hitomi Kataoka
authors.initials: HK
authors.lastname: Usui
authors.forename: Yanqing
authors.initials: Y
authors.lastname: Zhu
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Dunn
authors.forename: Raogo
authors.initials: R
authors.lastname: Ouedraogo
authors.forename: Kelly
authors.initials: K
authors.lastname: Hough
authors.forename: Peter
authors.initials: P
authors.lastname: McCue
authors.forename: Lawrence
authors.initials: L
authors.lastname: Chan
authors.forename: Bonita
authors.initials: B
authors.lastname: Falkner
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Goldstein
mesh_terms: D055372:AMP-Activated Protein Kinases; D052242:Adiponectin / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000418:Albumins / Q000378:metabolism; D000419:Albuminuria / Q000378:metabolism*; D000818:Animals; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology / Q000652:urine; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009097:Multienzyme Complexes / Q000378:metabolism; D000074663:NADPH Oxidase 4; D019255:NADPH Oxidases / Q000235:genetics / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000652:urine; D018384:Oxidative Stress; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism; D050199:Podocytes / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D062826:Zonula Occludens-1 Protein
chemical_list: D052242:Adiponectin; D000418:Albumins; D008565:Membrane Proteins; D009097:Multienzyme Complexes; D010750:Phosphoproteins; C569042:TJP1 protein, human; C569043:Tjp1 protein, mouse; D062826:Zonula Occludens-1 Protein; D000074663:NADPH Oxidase 4; D019255:NADPH Oxidases; C422943:Nox4 protein, mouse; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases